期刊文献+

托吡酯对癫患儿酸碱平衡及电解质代谢影响的研究 被引量:1

Effect of topiramate on acid-base balance and electrolytes metabolism in epileptic children.
原文传递
导出
摘要 目的 探讨托吡酯(TPM)对癫患儿酸碱平衡、电解质代谢的影响。方法 将2 0 0 2年3月至2 0 0 3年1 0月于河北医科大学附属第二医院儿科就诊的46例癫患儿根据治疗方法不同分成2组:( 1 )单药组2 6例(单独服用TPM) ;( 2 )联合用药组2 0例,为TPM与卡马西平(CBZ)、丙戊酸钠(VPA)、硝基安定(NZP)等联合应用。分别观察用药前(A时段)、用药后1~3个月(B时段)、用药3~1 2个月(C时段) 3个时段血气及电解质变化。结果 单药组血浆HCO- 3(mmol/L)A时段( 2 0 .1 0±2 .48) ,B时段( 1 6 .2 7±1 .0 6) ,C时段( 1 7 .82±1 . 79) ;联合用药组血浆HCO- 3(mmol/L)A时段( 2 2 . 1 0±2. 57) ,B时段( 1 5 .63±1 . 65) ,C时段( 1 6. 1 3±1 .0 7)。与本组A时段比较,两组用药后不同时段差异均分别具有显著性意义(P <0 . 0 1 )。但两组之间各时段差异均无显著性意义(P >0 .0 5)。结论 TPM可致癫患儿代偿性阴离子间隙正常型高氯性代谢性酸中毒。 Objective To investigate the effect of topiramate (TPM) on acid-base balance and electrolytes metabolism. Method All 46 epileptic children who had normal function of liver and kidney were divided into two groups: Single drug group(TPM only) and Combined drug group(combination of TPM with CBZ, VPA or NZP). The changes of blood gas and electrolytes were observed in three different times: before drug (Time A), 1~3 months after drug (Time B) and 3~12 months after drug (Time C). Results HCO - 3 of plasma (mmol/L) in Single drug group was 20.10±2.48,16.27±1.06 and 17.82±1.79 in Time A, Time B and Time C, respectively. HCO - 3 of plasma(mmol/L) in Combined drug group was 22.10±2.57,15.63±1.65 and 16.13±1.07 in Time A, Time B and Time C, respectively. For these two groups, there was significant difference of HCO - 3 in Time B and C compared with Time A (P<0.01), but no difference between the two groups (P>0.05). Conclusion TPM can induce normal anion gap metabolic acidosis and electrolytes disorder in epilepsia children.
出处 《中国实用儿科杂志》 CSCD 北大核心 2005年第4期218-220,共3页 Chinese Journal of Practical Pediatrics
基金 河北省科技攻关计划课题 (项目编号 0 42 761 1 4 4)
关键词 托吡酯 癫痫 碳酸酐酶抑制剂 阴离子间隙正常型代谢性酸中毒 Topiramate Epilepsy Carbonic anhydrase inhibitors Normal anion gap metabolic acidosis
  • 相关文献

参考文献9

  • 1Philippi H, Boor R, Reitter B. Topiramate and metabolic acidosis in infants and toddlers. Epilepsia, 2002,43(7):744-747.
  • 2Masereel B, Rolin S, Abbate F, et al. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. J Med Chem, 2002, 45(2):312-320.
  • 3Supuran CT, Scozzafara A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev, 2003,23(1): 146-189.
  • 4Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia, 2000, 41(Suppl) :35-39.
  • 5Takeoka M, Holmes GL, Thiele E, et al. Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia, 2001, 42 (3):387-392.
  • 6Kossoff EH, Pyzik PL, Furth SL, et al. Kidney stones, carbonic anhydrase ihhibitors, and the ketogenic diet. Epilepsia, 2002,43(10):1168-1171.
  • 7Ferriols LR,Heras JA,Sauz MM,et al. Acute renal failure probably associated with topirarmate. Farm Hosp,2003,27(2) :105-108.
  • 8Wilner A, Raymond K, Pollard R. Topirarmate and metabolic acidosis. Epilepsia, 1999, 40(6): 792-795.
  • 9Takeoka M, Riviello JJ Jr, Pfeifer H, et al. Concomitant treatment with topiramate and ketngenic diet in pediatric epilepsy.Epilepsia, 2002,43(9): 1072-1075.

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部